A61P 13 - Drugs for disorders of the urinary system

Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
11/2006
11/02/2006	US20060247223 Non-imidazole alkylamines as histamine H3- receptor ligands and their therapeutic applications
11/02/2006	US20060247160 Administering a polypeptide or biologically active fragment; reducing body mass; metabolic-related diseases, hyperlipidemias, atherosclerosis, diabetes, and hypertension
11/02/2006	US20060246504 Detection and treatment of polycystic kidney disease
11/02/2006	US20060246164 Medicament containing Epimedium extract for treatment of prostatic hyperplasia and prostatitis
11/02/2006	US20060246153 Herbal compositions for the teatment and prevention of prostate disorders
11/02/2006	US20060246066 Cleavable reagents for specific delivery to disease sites
11/02/2006	EP1717230A1 Fused-ring 4-oxopyrimidine derivative
11/02/2006	EP1717225A1 Bicyclic amide derivatives
11/02/2006	EP1715890A1 Ctgf as target for the therapy of diabetic nephropathy
11/02/2006	EP1509215B1 Treatment or prevention of urogenital atrophy and its symptoms in women
11/02/2006	EP1448195B1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
11/02/2006	EP1401801B1 Selective androgen receptor modulators and methods of use thereof
11/02/2006	EP1395568B1 4-aminopyrimidine derivatives
11/02/2006	EP1337243B1 Delayed-release pharmaceutical formulations containing proinsulin c-peptide
11/02/2006	EP1003721B1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
11/02/2006	CA2606064A1 Methods for modulating bladder function
11/02/2006	CA2605594A1 Heterocyclic compound
11/02/2006	CA2605381A1 Crystal polymorphism of 4'-{2-[(1s,2r)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethylamino]ethoxy}-3-isopropyl-3',5'-dimethylbiphenylcarboxylic acid hydrochloride
11/02/2006	CA2605267A1 Acetylene derivatives
11/01/2006	CN1853708A Use of Galangal fruit and its extract in pharmacy
11/01/2006	CN1853687A Use of safflower composition in preparation medicine for treating urinary tract infection
11/01/2006	CN1853667A Use of Dafabiao extract in pharmacy
11/01/2006	CN1853632A Herba fibraurae recisae soft capsules and production thereof
11/01/2006	CN1282640C N-arylphenylacetamide derivatives and medicinal compositions containing same
11/01/2006	CN1282636C Vitamin D analogues
11/01/2006	CN1282481C Chinese medicine and prescription for treatment of hypertrophy of prostate
11/01/2006	CN1282478C Traditional Chinese medicine preparation for treating uremia and its preparation method
10/2006
10/31/2006	US7129366 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions
10/31/2006	US7129356 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/31/2006	US7129270 Antiinflammatory agents
10/31/2006	US7129258 Substituted benzoxazoles as estrogenic agents
10/31/2006	US7129253 Compounds
10/31/2006	US7129246 N-adamantlmethyl derivatives and intermediates as pharmaceutical compositions and processes for their preparation
10/31/2006	US7129243 Respiratory system disorders; cardiovascular disorders; antidiabetic agents; antiarthritic agents; antiinflammatory agents; immunosuppressants
10/31/2006	US7129242 Such as 4-((4-chlorophenyl)pyrimidin-2-yl)amino)benzamide; for treatment of inflammation/autoimmune conditions
10/31/2006	US7129241 Pyridazine derivatives
10/31/2006	US7129240 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them
10/31/2006	US7129236 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
10/31/2006	US7129064 Canine hepatocyte growth factor
10/31/2006	US7128913 Erythropoietin conjugates
10/31/2006	US7128905 methods of preventing and treating diseases wherein the involvement of apoptosis has been indicated.
10/31/2006	CA2355886C Substituted oximes and hydrazones as neurokinin antagonists
10/26/2006	WO2006112933A1 Antibodies and related molecules that bind to psca proteins
10/26/2006	WO2006112331A1 Novel condensed pyrrole derivative
10/26/2006	WO2005102301A3 Hydroxymethylbutyrate compositions and uses thereof
10/26/2006	US20060242716 Disease model animal carrying foreign ppar alpha gene transferred thereinto and use thereof
10/26/2006	US20060241132 Spiro derivatives and adhesion molecule inhibitors comprising the same as active ingredient
10/26/2006	US20060241116 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates
10/26/2006	US20060241096 Agent for preventing or treating organ functional disorders and organ dysfunction
10/26/2006	US20060241066 Decoy composition for treating and preventing inflammatory disease
10/26/2006	US20060241051 Metastin derivatives and use thereof
10/26/2006	US20060240520 monitoring the efficacy of a BAFF-R (a B-cell activating factor belonging to the Tumor Necrosis Factor family) antagonist in the treatment of a disease or disorder associated with aberrant levels of B-cells or B-cell activity
10/26/2006	US20060240519 Novel receptor nucleic acids and polypeptides
10/26/2006	US20060240518 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells
10/26/2006	US20060240517 Novel receptor nucleic acids and polypeptides
10/26/2006	US20060240113 Anticancer agents; prevent forming blood vessels; removal blockager
10/26/2006	DE102005019458A1 Composition, useful in the preparation of pellets and the multi-particular-presentation form, comprises cefuroximaxetil and carrageenan of the group of lambda carrageenan, tau carrageenan and kappa carrageenan
10/25/2006	EP1714979A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/25/2006	EP1714965A1 Composition containing solifenacin succinate
10/25/2006	EP1714652A2 Use of thiazolidinediones to prevent or delay onset of niddm
10/25/2006	EP1714648A1 Combination drug
10/25/2006	EP1714643A1 Sustained release preparation
10/25/2006	EP1713769A1 Amorphous tamsulosin hydrochloride
10/25/2006	EP1524971B1 Improved transdermal delivery system
10/25/2006	EP1509498B1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
10/25/2006	EP1458718B1 Quinolinones as prostaglandin receptor ligands
10/25/2006	EP1430053B1 AZAOXOINDOLE DERIVATIVES AS Trk PROTEIN KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND CHRONIC PAIN
10/25/2006	EP1109901B1 GABA B RECEPTOR SUBTYPES GABA B-R1c AND GABA B-R2 AND HETERODIMERS THEREOF
10/25/2006	EP0827408B1 Method of administration of igf-i
10/25/2006	CN1850820A Coumarin derivatives, and their preparing method and use as alpha, receptor agonist
10/25/2006	CN1850266A Chinese patent medicine for treating nephritis damp swelling syndrome and preparing method
10/25/2006	CN1850265A Chinese medicine for treating nephrosis Yang deficiency syndrome
10/25/2006	CN1850251A Medicine for treating nephrosis syndrome
10/25/2006	CN1850225A Chinese patent medicine for treating astenia wind-heat syndrome and preparing method
10/25/2006	CN1850220A Medicine composition for treating urinary system stone and inflammation
10/25/2006	CN1850204A Medicine composition for resisting exogenous cold and high fever, and its preparing method
10/25/2006	CN1850181A Chinese patent medicine for treating nephritis Yang asthenia
10/25/2006	CN1850169A Melissa powder composition with function of preventing and treating prostate disease and relative diseases
10/25/2006	CN1850158A Tanshinoue dropping pills and preparing method
10/25/2006	CN1850149A Compounded preparation of Radix As tragali seu Hedy ari extract and mushroom polysaccharide and preparing method
10/25/2006	CN1850147A Medicine for treating gonorrhea
10/25/2006	CN1850129A Medicine preparation for preventing and treating heart brain and kidney blood vessel diseases
10/25/2006	CN1850087A Effervescent tablet containing cefixime and its preparing method
10/25/2006	CN1281608C New azo-indolyl derivatives
10/25/2006	CN1281598C Compounds and methods for modulation of estrogen receptors
10/25/2006	CN1281588C Novel intermediate for preparation of pyrazolopyrimidinones
10/25/2006	CN1281266C Chinese medicine for treating enuresis in children and preparation method thereof
10/25/2006	CN1281258C Cosmetic use of hop and ornithine
10/25/2006	CN1281252C Medicinal composition for treating urinary lithiasis and its preparing method
10/25/2006	CN1281239C Chinese medicine composition for treating stone
10/25/2006	CN1281227C Bunao Yishen Runchang Capsule for replenishing brain and kidney and moistening intestines
10/24/2006	US7125906 Indole derivatives having anti-angiogenetic activity
10/24/2006	US7125898 Kinase inhibitors to mediate disease and as antiinflammatory agents
10/24/2006	US7125895 Arylalkylamine compounds as chemokine receptor antagonists for therapy and prevention of diseases such as arthritis or rheumatic diseases
10/24/2006	US7125889 Administering mixtures of heterocyclic imines and anticoagulants such as heparin or aspirin, to reduce blood coagualtion in mammals
10/24/2006	US7125887 Pyrrolidine modulators of CCR5 chemokine receptor activity
10/24/2006	US7125883 alpha v beta 3 integrin receptor modulators; treating variety of diseases including cardiovascular disorders, retinopathy, strokes, cancer, osteoporosis, tumor metastasis, high blood pressure, psoriasis, antiviral, antimycotic, antiparasitic or antibacterial therapy; 1,2-dihydropyrimidin-2-one moiety
10/24/2006	US7125877 Brain disorders; psychological disorders; central nervous system disorders; antidiabetic agents; hypotensive agents
10/24/2006	US7125873 Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/24/2006	US7125688 A feline hepatocyte growth factor gene and a 15 base pairs-deleted feline hepatocyte growth factor gene. These genes encode the following protein (a) or (b): a protein having an amino acid sequence shown in SEQ ID NO: 2 or 4; and a protein

1 ... 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 ... 562